Shots: Transgene to receive $10M upfront & $3M preclinical milestones, providing its oncolytic virus expertise with Vaccinia Virus (TK-, RR-) double-deleted backbone and will take care of in-vitro pre-clinical development […]readmore
Tags : Oncolytic Immunotherapies